Similarly, CTNNB1-mutant cases, which benefit from the progression and proliferation caused by the activation of WNT/CTNNB1 signaling [6, 43], may protect cells from the adverse effects of this pathway activation with the help of the alleviated CIN. The gene discussed is CTNNB1; the disease is cervical squamous intraepithelial neoplasia.